SE9901572D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE9901572D0 SE9901572D0 SE9901572A SE9901572A SE9901572D0 SE 9901572 D0 SE9901572 D0 SE 9901572D0 SE 9901572 A SE9901572 A SE 9901572A SE 9901572 A SE9901572 A SE 9901572A SE 9901572 D0 SE9901572 D0 SE 9901572D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- solvates
- pharmaceutically acceptable
- new compounds
- carboxypeptidase
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000012453 solvate Substances 0.000 abstract 3
- 102000003847 Carboxypeptidase B2 Human genes 0.000 abstract 2
- 108090000201 Carboxypeptidase B2 Proteins 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/09—Diamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (53)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901572A SE9901572D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
| ARP000102082A AR028826A1 (es) | 1999-05-03 | 2000-04-28 | Compuestos que inhiben carboxipeptidasas, un proceso para su preparacion, una formulacion farmaceutica que los contiene y uso de los mismos para la fabricacion de un medicamento |
| ARP000102084A AR023819A1 (es) | 1999-05-03 | 2000-04-28 | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
| MYPI20001884A MY126962A (en) | 1999-05-03 | 2000-05-02 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| NZ515063A NZ515063A (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| HU0201615A HUP0201615A3 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| EEP200100578A EE200100578A (et) | 1999-05-03 | 2000-05-03 | Karboksüpeptidaasi U inhibiitorit ja trombiini inhibiitorit sisaldav ravimpreparaat |
| CA002371215A CA2371215A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
| AU44472/00A AU763772B2 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| HK02104304.1A HK1042493A1 (zh) | 1999-05-03 | 2000-05-03 | 新的化合物 |
| IL14595100A IL145951A0 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| SK1566-2001A SK15662001A3 (sk) | 1999-05-03 | 2000-05-03 | Nové zlúčeniny |
| US09/600,660 US7354895B1 (en) | 1999-05-03 | 2000-05-03 | Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| HU0202379A HUP0202379A3 (en) | 1999-05-03 | 2000-05-03 | New compounds, process for producing them and pharmaceutical compositions containing them |
| AU44471/00A AU4447100A (en) | 1999-05-03 | 2000-05-03 | New compounds |
| IL14595300A IL145953A0 (en) | 1999-05-03 | 2000-05-03 | A new inhibitor of carboxypeptidase u |
| TR2001/03144T TR200103144T2 (tr) | 1999-05-03 | 2000-05-03 | Yeni bileşikler |
| BR0010256-3A BR0010256A (pt) | 1999-05-03 | 2000-05-03 | Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, método de tratamento ou profilaxia de condições associadas com a inibição da carboxipeptidase u, kit de partes, e, método de tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da carboxipeptidase u e um mecanismo antitrombótico diferente são necessários |
| CZ20013932A CZ20013932A3 (cs) | 1999-05-03 | 2000-05-03 | Farmaceutický prostředek obsahující inhibitor karboxyperoxidasy U a inhibitor thrombinu |
| SK1565-2001A SK15652001A3 (sk) | 1999-05-03 | 2000-05-03 | Farmaceutický prípravok obsahujúci inhibítor karboxypeptidázy U a inhibítor trombínu |
| US09/600,659 US6974800B1 (en) | 1999-05-03 | 2000-05-03 | Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor |
| HK02104301.4A HK1042442B (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| AT00925845T ATE447964T1 (de) | 1999-05-03 | 2000-05-03 | Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor |
| EEP200100573A EE200100573A (et) | 1999-05-03 | 2000-05-03 | Uued ühendid, nende valmistamise meetod ning kasutamine |
| ES00925845T ES2335383T3 (es) | 1999-05-03 | 2000-05-03 | Una formulacion farmaceutica que contiene un inhibidor de carboxipeptidasa y un inhibidor de trombina. |
| EP00925844A EP1180099A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
| PCT/SE2000/000846 WO2000066550A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
| DE60043297T DE60043297D1 (de) | 1999-05-03 | 2000-05-03 | Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor |
| KR1020017014014A KR20020010631A (ko) | 1999-05-03 | 2000-05-03 | 신규 화합물 |
| CNB008071284A CN100518820C (zh) | 1999-05-03 | 2000-05-03 | 含有羧肽酶u抑制剂和凝血酶抑制剂的药物制剂 |
| KR1020017014009A KR100725206B1 (ko) | 1999-05-03 | 2000-05-03 | 카르복시펩티다제 ｕ 억제제 및 트롬빈 억제제를 함유하는제약 제제 |
| PCT/SE2000/000847 WO2000066152A1 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| TW089108401A TWI232106B (en) | 1999-05-03 | 2000-05-03 | Pharmaceutical compositions and kits of parts for the treatment of a patient suffering from or susceptible to a condition in which inhibition of thrombin and/or inhibition of carboxypeptidase U are required or desired |
| JP2000615381A JP4270759B2 (ja) | 1999-05-03 | 2000-05-03 | 新規化合物 |
| CZ20013931A CZ20013931A3 (cs) | 1999-05-03 | 2000-05-03 | Nové sloučeniny |
| MXPA01011043A MXPA01011043A (es) | 1999-05-03 | 2000-05-03 | Compuestos novedosos que inhiben las carboxipeptidasas basicas. |
| RU2001128158/15A RU2242992C2 (ru) | 1999-05-03 | 2000-05-03 | Фармацевтический препарат, содержащий ингибитор карбоксипептидазы u и ингибитор тромбина |
| MXPA01011044A MXPA01011044A (es) | 1999-05-03 | 2000-05-03 | Formulacion farmaceutica que contiene un inhibidor de carboxipeptidasa u y un inhibidor de trombina.. |
| PL356119A PL203505B1 (pl) | 1999-05-03 | 2000-05-03 | Preparat farmaceutyczny zawieraj acy inhibitor karboksypeptydazy U i inhibitor trombiny, zestaw sk ladników i zastosowanie preparatu farmaceutycznego |
| PL00356140A PL356140A1 (en) | 1999-05-03 | 2000-05-03 | New compounds |
| CN00809484A CN1358187A (zh) | 1999-05-03 | 2000-05-03 | 新的化合物 |
| TR2001/03151T TR200103151T2 (tr) | 1999-05-03 | 2000-05-03 | Karboksipeptidaz U inhibitörü ile trombin inhibitörünü içeren farmasötik bir formülasyon. |
| EP00925845A EP1181048B1 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| CA002371217A CA2371217A1 (en) | 1999-05-03 | 2000-05-03 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor |
| BR0010255-5A BR0010255A (pt) | 1999-05-03 | 2000-05-03 | Formulação farmacêutica, kit de partes, método para tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da trombina e/ou inibição da carboxipeptidase u são requeridas ou desejadas, e, uso de uma formulação |
| JP2000615036A JP2002543148A (ja) | 1999-05-03 | 2000-05-03 | カルボキシペプチダーゼｕ阻害剤とトロンビン阻害剤とを含有する医薬製剤 |
| NO20015308A NO20015308L (no) | 1999-05-03 | 2001-10-30 | En farmasoytisk formulering som inneholder en inhibitor av karboksypeptidase U og A trombininhibitor |
| ZA200108966A ZA200108966B (en) | 1999-05-03 | 2001-10-30 | A pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor. |
| ZA200108967A ZA200108967B (en) | 1999-05-03 | 2001-10-30 | New compounds. |
| IS6141A IS6141A (is) | 1999-05-03 | 2001-11-01 | Ný efnasambönd |
| IS6140A IS6140A (is) | 1999-05-03 | 2001-11-01 | Lyfjablanda sem inniheldur hemil karboxýpeptíðasaU og þrombínhemil |
| NO20015374A NO20015374D0 (no) | 1999-05-03 | 2001-11-02 | Nye forbindelser |
| US11/293,060 US7423012B2 (en) | 1999-05-03 | 2005-12-02 | Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9901572A SE9901572D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9901572D0 true SE9901572D0 (sv) | 1999-05-03 |
Family
ID=20415425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9901572A SE9901572D0 (sv) | 1999-05-03 | 1999-05-03 | New compounds |
Country Status (23)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001019836A1 (en) * | 1999-09-14 | 2001-03-22 | Meiji Seika Kaisha, Ltd. | Phosphonic acid derivatives having carboxypeptidase b inhibitory activity |
| PT1311488E (pt) * | 2000-08-17 | 2009-12-30 | Pfizer Ltd | Imidazóis substituídos utilizados como inibidores de tafia |
| SE0103272D0 (sv) | 2001-09-28 | 2001-09-28 | Astrazeneca Ab | Chemical compounds |
| EP1467731A1 (en) * | 2002-01-22 | 2004-10-20 | Pfizer Limited | 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| CA2472239A1 (en) | 2002-01-22 | 2003-07-31 | Pfizer Inc. | 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| US6713496B2 (en) | 2002-01-22 | 2004-03-30 | Pfizer Inc | 3-(imidazolyl)-2-alkoxypropanoic acids |
| KR100972717B1 (ko) | 2002-03-21 | 2010-07-27 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 혈장 카르복시펩티드분해효소 ｂ 억제제 |
| AU2009310841A1 (en) | 2008-10-29 | 2010-05-06 | Taisho Pharmaceutical Co., Ltd. | Compounds having TAFIa inhibitory activity |
| MY206577A (en) | 2019-02-08 | 2024-12-24 | Astrazeneca Ab | Arginase inhibitors and methods of use thereof |
| CN111110837B (zh) * | 2020-01-06 | 2022-11-25 | 中国人民解放军陆军军医大学 | 一种羧肽酶抑制剂在制备预防重症致死性轮状病毒感染药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2516307A (en) * | 1949-01-06 | 1950-07-25 | Gen Mills Inc | Vinyl resins plasticized with cyano esters |
| US4560680A (en) * | 1982-03-15 | 1985-12-24 | E. R. Squibb & Sons, Inc. | Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors |
| US4849414A (en) * | 1986-06-11 | 1989-07-18 | E. R. Squibb & Sons, Inc. | Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors |
| FR2610951B1 (fr) * | 1987-02-17 | 1989-05-05 | Aerospatiale | Armature tissee pour materiau composite |
| IL86951A (en) * | 1987-07-06 | 1996-07-23 | Procter & Gamble Pharma | Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them |
| HUT68010A (en) * | 1991-12-17 | 1995-05-29 | Procter & Gamble Pharma | The use of bisphonates and parathyroid hormone for the treatment of osteoporosis |
| US5550119A (en) * | 1995-03-02 | 1996-08-27 | Ciba-Geigy Corporation | Phosphono substituted tetrazole derivatives as ECE inhibitors |
| US5672592A (en) * | 1996-06-17 | 1997-09-30 | Guilford Pharmaceuticals Inc. | Certain phosphonomethyl-pentanedioic acid derivatives thereof |
| JP3440305B2 (ja) * | 1997-04-02 | 2003-08-25 | 高砂香料工業株式会社 | ７−（ｎ−置換アミノ）−２−フェニルヘプタン酸 エステル誘導体及び該誘導体の製造方法 |
| AU748998B2 (en) | 1997-02-27 | 2002-06-13 | Wyeth Holdings Corporation | N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| AR023819A1 (es) * | 1999-05-03 | 2002-09-04 | Astrazeneca Ab | FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION |
| SE9901573D0 (sv) * | 1999-05-03 | 1999-05-03 | Astra Ab | New compounds |
| WO2001019836A1 (en) * | 1999-09-14 | 2001-03-22 | Meiji Seika Kaisha, Ltd. | Phosphonic acid derivatives having carboxypeptidase b inhibitory activity |
-
1999
- 1999-05-03 SE SE9901572A patent/SE9901572D0/xx unknown
-
2000
- 2000-04-28 AR ARP000102082A patent/AR028826A1/es not_active Application Discontinuation
- 2000-05-03 SK SK1566-2001A patent/SK15662001A3/sk unknown
- 2000-05-03 HU HU0202379A patent/HUP0202379A3/hu unknown
- 2000-05-03 EP EP00925844A patent/EP1180099A1/en not_active Ceased
- 2000-05-03 PL PL00356140A patent/PL356140A1/xx not_active Application Discontinuation
- 2000-05-03 JP JP2000615381A patent/JP4270759B2/ja not_active Expired - Fee Related
- 2000-05-03 TR TR2001/03144T patent/TR200103144T2/xx unknown
- 2000-05-03 MX MXPA01011043A patent/MXPA01011043A/es unknown
- 2000-05-03 HK HK02104304.1A patent/HK1042493A1/zh unknown
- 2000-05-03 BR BR0010256-3A patent/BR0010256A/pt not_active Application Discontinuation
- 2000-05-03 CA CA002371215A patent/CA2371215A1/en not_active Abandoned
- 2000-05-03 US US09/600,660 patent/US7354895B1/en not_active Expired - Fee Related
- 2000-05-03 CN CN00809484A patent/CN1358187A/zh active Pending
- 2000-05-03 CZ CZ20013931A patent/CZ20013931A3/cs unknown
- 2000-05-03 AU AU44471/00A patent/AU4447100A/en not_active Abandoned
- 2000-05-03 KR KR1020017014014A patent/KR20020010631A/ko not_active Withdrawn
- 2000-05-03 IL IL14595300A patent/IL145953A0/xx unknown
- 2000-05-03 EE EEP200100573A patent/EE200100573A/xx unknown
- 2000-05-03 WO PCT/SE2000/000846 patent/WO2000066550A1/en not_active Ceased
-
2001
- 2001-10-30 ZA ZA200108966A patent/ZA200108966B/en unknown
- 2001-10-30 ZA ZA200108967A patent/ZA200108967B/en unknown
- 2001-11-01 IS IS6141A patent/IS6141A/is unknown
- 2001-11-02 NO NO20015374A patent/NO20015374D0/no not_active Application Discontinuation
-
2005
- 2005-12-02 US US11/293,060 patent/US7423012B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SK15662001A3 (sk) | 2002-09-10 |
| ZA200108967B (en) | 2003-01-30 |
| US7354895B1 (en) | 2008-04-08 |
| NO20015374L (no) | 2001-11-02 |
| HK1042493A1 (zh) | 2002-08-16 |
| JP2002543179A (ja) | 2002-12-17 |
| IL145953A0 (en) | 2002-11-10 |
| IS6141A (is) | 2001-11-01 |
| WO2000066550A1 (en) | 2000-11-09 |
| KR20020010631A (ko) | 2002-02-04 |
| BR0010256A (pt) | 2002-02-13 |
| AU4447100A (en) | 2000-11-17 |
| HUP0202379A2 (hu) | 2002-12-28 |
| CN1358187A (zh) | 2002-07-10 |
| NO20015374D0 (no) | 2001-11-02 |
| WO2000066550A8 (en) | 2001-01-25 |
| TR200103144T2 (tr) | 2004-11-22 |
| US7423012B2 (en) | 2008-09-09 |
| EP1180099A1 (en) | 2002-02-20 |
| AR028826A1 (es) | 2003-05-28 |
| MXPA01011043A (es) | 2002-06-04 |
| EE200100573A (et) | 2003-02-17 |
| US20060079484A1 (en) | 2006-04-13 |
| CZ20013931A3 (cs) | 2002-04-17 |
| CA2371215A1 (en) | 2000-11-09 |
| ZA200108966B (en) | 2003-01-30 |
| HUP0202379A3 (en) | 2003-04-28 |
| PL356140A1 (en) | 2004-06-14 |
| JP4270759B2 (ja) | 2009-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9901573D0 (sv) | New compounds | |
| RU95102778A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования потерь костной ткани и снижения уровня холестерина в сыворотке, фармацевтический препарат, содержащий 2-фенил-3-ароилбензотиофен | |
| GEP20053673B (en) | Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents | |
| AP1818A (en) | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | |
| CY1107850T1 (el) | Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους | |
| SE0202462D0 (sv) | Novel use | |
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| CY1107753T1 (el) | 2,5-δισυποκατεστημενο 3-μερκαπτοπεντανοϊκο οξυ | |
| DK0920865T3 (da) | Farmaceutiske sammensætninger indeholdende norastemizol | |
| NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
| SE0002476D0 (sv) | New compounds | |
| SE0102440D0 (sv) | New compound | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| HK1042493A1 (zh) | 新的化合物 | |
| DE69931378D1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
| HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| DE60233578D1 (de) | Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung | |
| SE9900190D0 (sv) | New compounds | |
| TW200509915A (en) | Novel oxazoles, their manufacture and use as pharmaceutical agents | |
| DE602005017629D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis | |
| DE60022047D1 (de) | Antivirale therapie | |
| GEP20043356B (en) | Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor | |
| TW200500330A (en) | Pharmaceutical composition | |
| UY27855A1 (es) | Compuestos quimicos | |
| DE60104288D1 (de) | Antivirale therapie |